ABT vs AMZN · P/E 25, rev $44.33B vs P/E 31, rev $716.92B
Abbott Laboratories (ABT) versus Amazon.com Inc (AMZN) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
Amazon.com Inc (AMZN) is a internet retail company listed on NASDAQ. It is led by Andrew R. Jassy.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported AMZN revenue for 2025-12-31 was $716.92B. Net income was $77.67B. Revenue was up 12.4% from 2024-12-31 to 2025-12-31. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. AMZN currently screens at market cap $2.55T and trailing P/E 30.6.
Not investment advice. Open the ABT and AMZN stock pages for the full models.
Not investment advice.